Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that metformin is a first-line treatment for PCOS, particularly for restoring ovulation and increasing pregnancy rates, with other treatments depending on specific symptoms.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

Insulin resistance is linked to PCOS and can lead to other health issues, but treatments like metformin can help manage symptoms.

The study found that family history, personal history of adolescent acne, no pregnancies, hirsutism, office work, stress, and low intake of fruits/vegetables and fish are risk factors for adult female acne.

Losing weight and eating better are key to managing metabolic syndrome and its related conditions.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

Low-glycemic index diets are beneficial for weight loss and satiety, but more research is needed on long-term effects and individualized approaches are recommended.

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

Ayme-Gripp Syndrome was confirmed in a woman through genetic testing, highlighting the need to consider rare genetic conditions in diagnoses.

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Women with PCOS have overall higher body fat, not abnormal fat placement, and more insulin resistance.

Low birthweight and rapid weight gain after birth may increase the risk of developing polycystic ovary syndrome.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

Children with classic congenital adrenal hyperplasia have thicker heart fat and are at higher risk for heart problems and early atherosclerosis.

Metformin helps improve symptoms and reproductive outcomes in people with polycystic ovary syndrome.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

Testosterone therapy improved physical and social health in a male with 49,XXXXY syndrome.

Both oral contraceptives reduced hirsutism in PCOS patients, but adding metformin showed no extra benefit.

Long-COVID symptoms can last more than a year and change over time.

Spironolactone improved cognitive performance and early sleep quality but not manic symptoms, appetite, or body weight in bipolar disorder when added to sodium valproate.

Hormonal imbalances are a key cause of missed menstrual periods in women.

People with early-onset androgenetic alopecia may have a higher risk of heart disease due to abnormal blood lipid levels.